Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 1–50 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07737314	Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study	not yet recruiting	N/A	50	Fred Hutchinson Cancer CenterOTHER	1	Sep 28, 2026	clinicaltrials
NCT07844447	A Study of RT036 in Patients With Advanced Solid Tumors	not yet recruiting	Phase 1 / Phase 2	308	Shanghai Ruotuo Biosciences Co., Ltd.INDUSTRY	0	Sep 28, 2026	clinicaltrials